Claes Held
Uppsala University
2 papers in the Anchorcite directory, published between 2009 and 2019, cited 14,702 times in total.
ORCID profileResearch topics
- Cardiovascular Function and Risk Factors · 1 paper
- Diabetes Treatment and Management · 1 paper
- Heart Failure Treatment and Management · 1 paper
- Acute Myocardial Infarction Research · 1 paper
- Antiplatelet Therapy and Cardiovascular Diseases · 1 paper
- Coronary Interventions and Diagnostics · 1 paper
Frequent co-authors
- John J.V. McMurray · 1 paper
- Scott David Solomon · 1 paper
- Silvio E. Inzucchi · 1 paper
- Lars Køber · 1 paper
- Mikhail Kosiborod · 1 paper
- Felipe A. Martínez · 1 paper
- Piotr P. Ponikowski · 1 paper
- Marc Steven Sabatine · 1 paper
Papers
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionNew England Journal of Medicine · 2019 · 7,529 citations
BACKGROUND: In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the effects of SGLT2 inhibitors in patients with…
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 2009 · 7,173 citations
BACKGROUND: Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel. METHODS: In this multicenter, double-blind, randomized trial, we compared ticagrelor (180-mg loading dose,…
Metadata from OpenAlex (CC0).